Kardium

Kardium

Private
Burnaby, British ColumbiaHealthcare & Life Scienceshttps://www.kardium.com

Last Round

Series D

7/2/2025

Total Funding Raised

$510.1M

Momentum Score

25 /100

Company Overview

Kardium is a medical technology company that develops advanced devices for the diagnosis and treatment of atrial fibrillation, offering detailed electrophysiological mapping and radio-frequency energy solutions for cardiac tissue ablation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

pulsed field ablationPFAatrial fibrillationAFibcardiac ablationcardiac mappingAFGlobe Systemelectrophysiology systemsingle-catheter solutionradiofrequency ablationRF ablationmedtechelectrode array catheter3D mapping and navigationrazor-and-blades model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kardium Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kardium Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series D7/2/2025
Series B Extension6/11/2024
Debt1/9/2024
Series B1/25/2021
Series A2/7/2019

Key People

Founding team and executive leadership

Koert VandenEnden

Chief Financial Officer

Executive Team

Kardium Investors

Notable investors and investment history

InvestorRounds
MMCAP VenturesSeries D
Janus Henderson GroupSeries D
EckuitySeries D
Durable Capital Partners LPSeries D, Series B Extension
Eventide FundsSeries D
Fidelity Management & Research CompanySeries B, Series B Extension
T. Rowe PriceSeries D, Series B, Series B Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Globe Pulsed Field System receives FDA approval and begins commercial launch.

  • Oct 10, 2025

    Leased 225,000 sq ft across ten buildings.

Kardium Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kardium Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kardium's valuation, stock price, and market status.

Firmographic Details

HeadquartersBurnaby, British Columbia
Employee Range560
Year Founded2007
Last Funding7/2/2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.